Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 5 studies | 23% ± 4% | |
oligodendrocyte precursor cell | 5 studies | 22% ± 6% | |
oligodendrocyte | 4 studies | 22% ± 4% | |
endothelial cell | 4 studies | 18% ± 2% | |
GABAergic neuron | 3 studies | 29% ± 15% |
Insufficient scRNA-seq data for expression of INSYN2A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 357.31 | 2630 / 2642 | 90% | 8.72 | 636 / 705 |
breast | 70% | 96.57 | 322 / 459 | 52% | 11.46 | 576 / 1118 |
prostate | 98% | 199.47 | 240 / 245 | 9% | 0.21 | 47 / 502 |
lung | 80% | 65.09 | 460 / 578 | 12% | 0.74 | 144 / 1155 |
thymus | 73% | 35.37 | 475 / 653 | 13% | 0.54 | 81 / 605 |
intestine | 82% | 52.79 | 791 / 966 | 3% | 0.12 | 17 / 527 |
skin | 78% | 39.00 | 1411 / 1809 | 5% | 0.21 | 22 / 472 |
ovary | 74% | 51.38 | 134 / 180 | 1% | 0.03 | 6 / 430 |
bladder | 71% | 35.71 | 15 / 21 | 4% | 0.30 | 21 / 504 |
kidney | 70% | 49.98 | 62 / 89 | 5% | 0.23 | 47 / 901 |
uterus | 62% | 23.35 | 105 / 170 | 11% | 0.30 | 51 / 459 |
stomach | 67% | 35.34 | 242 / 359 | 4% | 0.25 | 11 / 286 |
spleen | 61% | 32.07 | 147 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 49% | 20.39 | 651 / 1335 | 0% | 0 | 0 / 0 |
adipose | 43% | 16.65 | 520 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 36% | 13.21 | 522 / 1445 | 2% | 0.03 | 3 / 183 |
pancreas | 12% | 4.15 | 38 / 328 | 12% | 0.46 | 22 / 178 |
heart | 15% | 4.71 | 128 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 9% | 2.88 | 23 / 258 | 5% | 0.20 | 11 / 230 |
muscle | 12% | 5.84 | 99 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.33 | 5 / 45 |
liver | 4% | 0.93 | 8 / 226 | 0% | 0.01 | 2 / 406 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
peripheral blood | 0% | 0.07 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060080 | Biological process | inhibitory postsynaptic potential |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005515 | Molecular function | protein binding |
Gene name | INSYN2A |
Protein name | Inhibitory synaptic factor 2A (InSyn2) |
Synonyms | INSYN2 FAM196A C10orf141 |
Description | FUNCTION: Component of the protein machinery at the inhibitory synapses, probably acting as a scaffold. Inhibitory synapses dampen neuronal activity through postsynaptic hyperpolarization. This synaptic inhibition is fundamental for the functioning of the central nervous system, shaping and orchestrating the flow of information through neuronal networks to generate a precise neural code. . |
Accessions | ENST00000522781.6 [Q6ZSG2-1] ENST00000424811.2 [Q6ZSG2-2] Q6ZSG2 ENST00000614311.4 [Q6ZSG2-2] |